英国支持的投资扩大了制药公司在西非各地可负担得起的药店网络。 UK-backed investment expands mPharma’s affordable pharmacy network across West Africa.

加纳增长投资伙伴在英国国际投资的支持下,向加纳制药公司投资,以便在包括多哥和贝宁在内的西非扩大负担得起的保健。 Growth Investment Partners Ghana, backed by British International Investment, has invested in mPharma Ghana to expand affordable healthcare across West Africa, including Togo and Benin. 这笔资金将增加制药商的Mutti药店网络和质量Rx特许模式,改善库存系统,并支持像Mutti医生这样的数字保健服务。 The funding will grow mPharma’s Mutti pharmacy network and QualityRx franchise model, improve inventory systems, and support digital health services like Mutti Doctor. 该公司成立于2013年,为六个非洲国家服务,其Mutti方案有40多万名成员,70%以上报告药品价格较低,75%以上没有库存。 The company, founded in 2013, serves six African countries and has over 400,000 members in its Mutti program, with more than 70% reporting lower drug prices and over 75% experiencing no stockouts. 有针对性的保健方案取得了显著成果,包括80%的糖尿病患者在六个月内实现了最佳血液糖控制。 Targeted health programs show strong results, including 80% of diabetes patients achieving optimal blood sugar control within six months. 战略伙伴关系确保了对关键药品高达65%的折扣。 Strategic partnerships have secured up to 65% discounts on key medicines.